• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2021 Dec 17;1-51.
doi: 10.1080/22221751.2021.2019559. Online ahead of print.
Enhanced replication fitness of MERS-CoV clade B over clade A strains in camelids explains the dominance of clade B strains in the Arabian Peninsula


Nigeer Te[SUP] 1 [/SUP], Jordi Rodon[SUP] 1 [/SUP], Mónica Pérez[SUP] 1 [/SUP], Joaquim Segalés[SUP] 2 3 [/SUP], Júlia Vergara-Alert[SUP] 1 [/SUP], Albert Bensaid[SUP] 1 [/SUP]



Affiliations

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) continues infecting humans and dromedary camels. While MERS-CoV strains from the Middle East region are subdivided into two clades (A and B), all the contemporary epidemic viruses belong to clade B. Thus, MERS-CoV clade B strains may display adaptive advantages over clade A in humans and/or reservoir hosts. To test this hypothesis in vivo, we compared an early epidemic clade A strain (EMC/2012) with a clade B strain (Jordan-1/2015) in an alpaca model monitoring virological and immunological parameters. Further, the Jordan-1/2015 strain has a partial amino acid (aa) deletion in the double stranded (ds) RNA binding motif of the open reading frame ORF4a protein. Animals inoculated with the Jordan-1/2015 variant had higher MERS-CoV replicative capabilities in the respiratory tract and larger nasal viral shedding. In the nasal mucosa, the Jordan-1/2015 strain caused an early IFN response, suggesting a role for ORF4a as a moderate IFN antagonist in vivo. However, both strains elicited maximal transcription of antiviral interferon stimulated genes (ISGs) at the peak of infection on 2 days post inoculation, correlating with subsequent decreased in tissular viral loads. Genome alignment analysis revealed several clade B specific amino acid substitutions occurring in the replicase and the S proteins, which could explain a better adaptation of clade B strains in camelid hosts. Differences in replication and shedding reported herein indicate a better fitness and transmission capability of MERS-CoV clade B strains than their clade A counterparts.

Keywords: IFN; MERS-CoV; Middle East respiratory syndrome coronavirus; ORF4a; alpaca; strain.
 
Back
Top Bottom